Walleye Capital LLC Sarepta Therapeutics, Inc. Transaction History
Walleye Capital LLC
- $46.2 Billion
- Q3 2024
A detailed history of Walleye Capital LLC transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Walleye Capital LLC holds 16,500 shares of SRPT stock, worth $1.92 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,500
Previous 24,800
33.47%
Holding current value
$1.92 Million
Previous $3.92 Million
47.42%
% of portfolio
0.0%
Previous 0.01%
Shares
15 transactions
Others Institutions Holding SRPT
# of Institutions
529Shares Held
84.1MCall Options Held
2.06MPut Options Held
1.52M-
Black Rock Inc. New York, NY10.3MShares$1.2 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.97MShares$1.04 Billion0.02% of portfolio
-
Capital International Investors Los Angeles, CA6.26MShares$729 Million0.16% of portfolio
-
Janus Henderson Group PLC London, X04.36MShares$508 Million0.29% of portfolio
-
State Street Corp Boston, MA4.27MShares$497 Million0.02% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $10.2B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...